Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Zeng

Showing results (1141-1150 of 1,217) with videos related to

Pageof 122
Sort By:
Molecular & Cellular Proteomics : MCP|March 22, 2006
A proteome reference map and proteomic analysis of Bifidobacterium longum NCC2705Jing Yuan, Li Zhu, Xiankai Liu, et al.
Translational Oncology|June 18, 2019
Telomere Maintenance-Associated PML Is a Potential Specific Therapeutic Target of Human Colorectal CancerPeng Gong, Hua Wang, Jingsong Zhang, et al.
American Journal of Nephrology|September 7, 2016
Parathyroidectomy Increases Heart Rate Variability and Leptin Levels in Patients with Stage 5 Chronic Kidney DiseaseYao Jiang, Zhixiang Shen, Jingjing Zhang, et al.
Molecular Medicine Reports|October 26, 2016
Alterations in the expression of Hs1-associated protein X-1 in the rat retina after optic nerve crushLing Cui, Wen-Jing He, Fan Xu, et al.
Acta Pharmacologica Sinica|December 3, 2024
Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axisYue-Kang Li, Fu-Jing Ge, Xiang-Ning Liu, et al.
Frontiers in Pharmacology|August 9, 2020
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective StudyYin-Qiu Huang, Sheng-Quan Tang, Xiao-Lei Xu, et al.
BMC Cancer|July 15, 2020
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysisYuemei Sun, Mengwan Wu, Mingxiu Zhou, et al.
JCI Insight|March 28, 2023
MEX3B inhibits collagen production in eosinophilic nasal polyps by downregulating epithelial cell TGFBR3 mRNA stabilityJin-Xin Liu, Ao-Nan Chen, Qihong Yu, et al.
The Journal of Biological Chemistry|January 2, 2007
Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8Xuedong Fan, Andriani C Patera, Amy Pong-Kennedy, et al.
Cancer Research|April 20, 2018
Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R-YAP AxisHong Zhu, Dan-Dan Wang, Tao Yuan, et al.
Pageof 122

Showing results (1141-1150 of 1,217) with videos related to

Sort By:
Pageof 122
Molecular & Cellular Proteomics : MCP|March 22, 2006
A proteome reference map and proteomic analysis of Bifidobacterium longum NCC2705Jing Yuan, Li Zhu, Xiankai Liu, et al.
Translational Oncology|June 18, 2019
Telomere Maintenance-Associated PML Is a Potential Specific Therapeutic Target of Human Colorectal CancerPeng Gong, Hua Wang, Jingsong Zhang, et al.
American Journal of Nephrology|September 7, 2016
Parathyroidectomy Increases Heart Rate Variability and Leptin Levels in Patients with Stage 5 Chronic Kidney DiseaseYao Jiang, Zhixiang Shen, Jingjing Zhang, et al.
Molecular Medicine Reports|October 26, 2016
Alterations in the expression of Hs1-associated protein X-1 in the rat retina after optic nerve crushLing Cui, Wen-Jing He, Fan Xu, et al.
Acta Pharmacologica Sinica|December 3, 2024
Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axisYue-Kang Li, Fu-Jing Ge, Xiang-Ning Liu, et al.
Frontiers in Pharmacology|August 9, 2020
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective StudyYin-Qiu Huang, Sheng-Quan Tang, Xiao-Lei Xu, et al.
BMC Cancer|July 15, 2020
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysisYuemei Sun, Mengwan Wu, Mingxiu Zhou, et al.
JCI Insight|March 28, 2023
MEX3B inhibits collagen production in eosinophilic nasal polyps by downregulating epithelial cell TGFBR3 mRNA stabilityJin-Xin Liu, Ao-Nan Chen, Qihong Yu, et al.
The Journal of Biological Chemistry|January 2, 2007
Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8Xuedong Fan, Andriani C Patera, Amy Pong-Kennedy, et al.
Cancer Research|April 20, 2018
Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R-YAP AxisHong Zhu, Dan-Dan Wang, Tao Yuan, et al.
Pageof 122